Cost of pretherapeutic staging of patients with colorectal cancer metastases in a French population - 25/05/11
, Pierre Logé c, Patrick Arveux d, Michel Velten e, Damien Jolly f, Marie-Christine Woronoff-Lemsi g, Francis Guillemin h
Corresponding author.Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
| pages | 9 |
| Iconographies | 0 |
| Vidéos | 0 |
| Autres | 0 |
Summary |
Background |
Little is known about the economic burden of pretherapeutic staging of patients presenting colorectal cancer metastases.
Objective |
The aim of this study was to estimate the cost of pretherapeutic staging and identify cost determinants for 132patients presenting colorectal metastases and living in the north-east of France.
Method |
Staging cost was estimated using direct medical costs from the point of view of the French Health Insurance System. Independent factors were identified using a linear regression model, and bootstrap resampling was used to estimate unbiased standard errors and 95% confidence intervals.
Results |
The overall mean cost for pretherapeutic staging was estimated to be 1534€ [95% CI: 1250€–1818€]. Staging costs increased significantly with the number of medical procedures performed during the staging, and according to health care patterns (in-patient hospital stay versus out-patient episodes, public versus private care).
Conclusion |
These results could now be used to estimate the impact of new imaging techniques on clinical practices and pretherapeutic staging costs.
Le texte complet de cet article est disponible en PDF.Plan
Vol 35 - N° 5
P. 399-407 - mai 2011 Retour au numéro
Article précédent
- PIAS3 expression in human gastric carcinoma and its adjacent non-tumor tissues
- Liang-ming Liu, Ming-guo Yan, Dao-hua Yang, Wei-wei Sun, Ji-xiang Zhang
- Liver transplantation for symptomatic centrohepatic biliary cystadenoma
- Renato Romagnoli, Damiano Patrono, Gianluca Paraluppi, Ezio David, Francesco Tandoi, Paolo Strignano, Francesco Lupo, Mauro Salizzoni
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?